ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.884,75
-0,57%
S&P 500
5.930,85
1,09%
Dow Jones
42.840,26
1,18%
Euro vs US Dollar
1,043
0,00%
Bitcoin
95.426,46
-1,83%
Pepperstone
Advertisement
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Aduro Biotech Inc (ADRO)

  7. Aduro Biotech Inc (ADRO) News

ADRO

Aduro Biotech (ADRO)

Aduro Biotech Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:ADRO
DatumZeitQuelleÜberschriftSymbolFirma
20/06/202315h06Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ADROAduro Biotech Inc
20/06/202315h01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADROAduro Biotech Inc
15/06/202322h18Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADROAduro Biotech Inc
14/06/202315h02Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ADROAduro Biotech Inc
12/06/202322h30Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ADROAduro Biotech Inc
12/06/202322h28Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADROAduro Biotech Inc
12/06/202322h07Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ADROAduro Biotech Inc
12/06/202315h42Edgar (US Regulatory)Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a)NASDAQ:ADROAduro Biotech Inc
12/06/202313h05Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ADROAduro Biotech Inc
12/06/202313h01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADROAduro Biotech Inc
01/06/202301h26Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADROAduro Biotech Inc
01/06/202301h23Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADROAduro Biotech Inc
01/06/202301h22Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADROAduro Biotech Inc
09/05/202322h10Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ADROAduro Biotech Inc
09/05/202322h04Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADROAduro Biotech Inc
05/05/202322h02Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ADROAduro Biotech Inc
28/04/202323h43Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:ADROAduro Biotech Inc
26/04/202323h20Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADROAduro Biotech Inc
19/04/202323h59Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADROAduro Biotech Inc
17/04/202322h52Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:ADROAduro Biotech Inc
13/04/202322h32Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADROAduro Biotech Inc
12/04/202322h57Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ADROAduro Biotech Inc
13/03/202311h02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADROAduro Biotech Inc
10/03/202322h14Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:ADROAduro Biotech Inc
03/03/202322h13Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADROAduro Biotech Inc
27/02/202322h05Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADROAduro Biotech Inc
16/02/202323h53Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ADROAduro Biotech Inc
15/02/202322h41Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADROAduro Biotech Inc
15/02/202322h40Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADROAduro Biotech Inc
14/02/202322h34Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ADROAduro Biotech Inc
 Showing the most relevant articles for your search:NASDAQ:ADRO

Kürzlich von Ihnen besucht

DBI
TDXP
Tec DAX
NASDAQ
NVDA
NVIDIA
NYSE
KO
Coca Cola
COIN
BTCUSD
Bitcoin
NASDAQ
QQQ
Invesco QQQ Trust Series 1
USOTC
BNPQY
BNP Paribas (QX)
COIN
XRPUSD
Ripple
PM
XAUUSD
Gold vs US Dollar
DBI
DAX
DAX
TG
DTE
Deutsche Telekom
USOTC
BASFY
BASF (QX)
TG
TUI1
Tui
NYSE
MCD
McDonalds
TG
LHA
Deutsche Lufthansa
NASDAQ
TSLA
Tesla
NASDAQ
AAPL
Apple
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten